Abnormal polyglutamine (polyQ) aggregation disrupts cellular proteostasis, triggers cytopathy, and induces neurodegenerative diseases, aggregation of polyQ protein elevating amyloidogenic processing of amyloid precursor protein by upregulating β-site amyloid precursor protein-cleaving enzyme 1 [17]. This evidence concerns the gene APP and neurodegenerative disease.